The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

David J. Gross

Department of Endocrinology and Metabolism

Hadassah University Hospital

P.O. Box 12000

91120

Israel

[email]@vms.huji.ac.il

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Endocrinology and Metabolism, Hadassah University Hospital, P.O. Box 12000, 91120, Israel. 2001 - 2006
  • Endocrinology and Metabolism Service and Department of Bone Marrow Transplantation and Cancer Immunobiology, Hadassah University Hospital, Jerusalem 91120, USA. 2003
  • Department of Endocrinology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel. 1998 - 1999

References

  1. The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R. Gross, D.J., Munter, G., Bitan, M., Siegal, T., Gabizon, A., Weitzen, R., Merimsky, O., Ackerstein, A., Salmon, A., Sella, A., Slavin, S. Endocr. Relat. Cancer (2006) [Pubmed]
  2. Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivo. Gross, D.J., Reibstein, I., Weiss, L., Slavin, S., Dafni, H., Neeman, M., Pines, M., Nagler, A. Clin. Cancer Res. (2003) [Pubmed]
  3. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus. Gross, D.J., Weiss, L., Reibstein, I., Hedlund, G., Dahlén, E., Rapoport, M.J., Slavin, S. Int. Immunopharmacol. (2001) [Pubmed]
  4. The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice. Gross, D.J., Reibstein, I., Weiss, L., Slavin, S., Stein, I., Neeman, M., Abramovitch, R., Benjamin, L.E. Clin. Cancer Res. (1999) [Pubmed]
  5. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment. Gross, D.J., Weiss, L., Reibstein, I., van den Brand, J., Okamoto, H., Clark, A., Slavin, S. Endocrinology (1998) [Pubmed]
 
WikiGenes - Universities